<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药物探索 | wechat-feeds</title><link>http://MzU3NzU1OTg1OQ.favicon.privacyhide.com/favicon.ico</link><description>医药相关领域的信息分享和分析</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 08 Jun 2021 21:37:18 +0800</pubDate><image><url>http://MzU3NzU1OTg1OQ.favicon.privacyhide.com/favicon.ico</url><title>药物探索 | wechat-feeds</title><link>http://MzU3NzU1OTg1OQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>首个KRAS上市，AMG510之后，还有哪些问题仍待解决</title><link>https://mp.weixin.qq.com/s/Vw3HqzjzSyidtGeeJVXxug</link><description></description><content:encoded><![CDATA[首个KRAS上市，AMG510之后，还有哪些问题仍待解决]]></content:encoded><pubDate>Sat, 29 May 2021 10:34:10 +0800</pubDate></item><item><title>FGFR抑制剂Infigratinib上市，联拓生物拥有中国开发权益</title><link>https://mp.weixin.qq.com/s/MjsG4N4aXqtPhuzXDjJTZA</link><description></description><content:encoded><![CDATA[FGFR抑制剂Infigratinib上市，联拓生物拥有中国开发权益]]></content:encoded><pubDate>Sat, 29 May 2021 10:34:10 +0800</pubDate></item><item><title>EGFR-MET双抗Amivantamab上市，ADC还远吗？</title><link>https://mp.weixin.qq.com/s/4iWUFLN3lFTb3I3BTrBK_g</link><description></description><content:encoded><![CDATA[EGFR-MET双抗Amivantamab上市，ADC还远吗？]]></content:encoded><pubDate>Sat, 22 May 2021 08:59:21 +0800</pubDate></item><item><title>EGFR四代BLU-945开临床，然而没啥想说的</title><link>https://mp.weixin.qq.com/s/EzlT1tehTOOhg3twIjreoA</link><description></description><content:encoded><![CDATA[EGFR四代BLU-945开临床，然而没啥想说的]]></content:encoded><pubDate>Thu, 29 Apr 2021 12:56:11 +0800</pubDate></item><item><title>AACR21｜八千里路云和月，一朝平步上青天</title><link>https://mp.weixin.qq.com/s/TYhMFvVi01k3IfWhCcVNAg</link><description></description><content:encoded><![CDATA[AACR21｜八千里路云和月，一朝平步上青天]]></content:encoded><pubDate>Sun, 11 Apr 2021 21:57:39 +0800</pubDate></item><item><title>AACR21｜RMC4630，SOS1和他家的其他报告</title><link>https://mp.weixin.qq.com/s/w1swvSgtH3oLnpEe-PI-kA</link><description></description><content:encoded><![CDATA[AACR21｜RMC4630，SOS1和他家的其他报告]]></content:encoded><pubDate>Sun, 11 Apr 2021 07:47:29 +0800</pubDate></item><item><title>勤浩医药再报一款KRAS，SHP2专利公开，能否授权？</title><link>https://mp.weixin.qq.com/s/avCu4Nv4QTTD9vOjrCldZg</link><description></description><content:encoded><![CDATA[勤浩医药再报一款KRAS，SHP2专利公开，能否授权？]]></content:encoded><pubDate>Fri, 02 Apr 2021 15:46:25 +0800</pubDate></item><item><title>伏美替尼价格出炉，石药买的三代EGFR诉讼结束没有？</title><link>https://mp.weixin.qq.com/s/gJ991Zr6nO29w7MFhVLxkw</link><description></description><content:encoded><![CDATA[伏美替尼价格出炉，石药买的三代EGFR诉讼结束没有？]]></content:encoded><pubDate>Thu, 18 Mar 2021 09:59:18 +0800</pubDate></item><item><title>EGFR四代药物，脑渗透性抑制剂来了</title><link>https://mp.weixin.qq.com/s/oVobrmJL7a_lOqYhx72zyw</link><description></description><content:encoded><![CDATA[EGFR四代药物，脑渗透性抑制剂来了]]></content:encoded><pubDate>Mon, 15 Mar 2021 00:17:15 +0800</pubDate></item><item><title>礼来宣布回归Kras G12C</title><link>https://mp.weixin.qq.com/s/NFvsLXvYGVLSZFmvMGuH7Q</link><description></description><content:encoded><![CDATA[礼来宣布回归Kras G12C]]></content:encoded><pubDate>Thu, 11 Mar 2021 11:22:16 +0800</pubDate></item><item><title>百济神州开启HPK1抑制剂BGB-15025患者给药</title><link>https://mp.weixin.qq.com/s/By59KUouJLeKeMXck-EN6A</link><description></description><content:encoded><![CDATA[百济神州开启HPK1抑制剂BGB-15025患者给药]]></content:encoded><pubDate>Wed, 10 Mar 2021 21:30:02 +0800</pubDate></item></channel></rss>